Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Necrotizing enterocolitis (NEC) is a commonly encountered disease of the gastrointestinal tract in premature infants. The aim of the study was to evaluate the therapeutic role of probiotics on NEC in a preterm rat model. NEC model was induced in preterm formula-fed rats, exposed daily to hypoxia, hypothermia, and administered pathogenic bacteria. Then rats were randomly divided into four different groups: control group, NEC group, NEC-antibiotic group, and NEC-probiotic group. All rats were sacrificed at the end of the experiment. Histological examination of ileal wall under light and electron microscopes was done, and TNF-α and IL-18 staining was also assessed. Statistical analysis of data was performed. Histological examination of the ileal mucosa of NEC group showed inflammatory infiltration, various degrees of separation of the submucosa, thinning of the wall, sloughing, and loss of the intestinal villi. The villus heights significantly decreased (p ≤ 0.05) in the NEC group. Electron micrographs demonstrated signs of enterocytic death, lost microvilli, abnormal nuclei, vacuolated cytoplasm, swollen mitochondria, and loss of junctional complexes. These findings were almost reversed in the probiotic group that regained the normal villous height, and to a lesser extent in the antibiotic group which was still significant compared to the CG (p ≤ 0.05). Immunohistochemical staining showed significantly increased expression of proinflammatory cytokines TNF-α and IL-18 (p ≤ 0.05) in the intestinal mucosa of the NEC group and NEC-antibiotic group as compared to the control group and the NEC-probiotic group. Probiotics could hold therapeutic potential for NEC in preterm neonatal rats.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12602-025-10611-5DOI Listing

Publication Analysis

Top Keywords

nec group
16
group
12
necrotizing enterocolitis
8
nec
8
nec preterm
8
control group
8
group nec-antibiotic
8
nec-antibiotic group
8
group nec-probiotic
8
nec-probiotic group
8

Similar Publications

Background: Necrotizing enterocolitis (NEC) is a gastrointestinal emergency in premature neonates. NEC is mediated by toll-like receptor-4 (TLR-4) and associated with lung injury. Previously, we showed that prenatal heparin-binding epidermal growth factor (HB-EGF) administration decreases the incidence of intestinal injury in a rat model of NEC.

View Article and Find Full Text PDF

Objectives: To investigate the effects of formulated granules of (TGY) on motor deficits in a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced subacute Parkinson's disease (PD) and explore the possible molecular mechanisms.

Methods: Ninety C57BL/6 mice were randomized equally into 6 groups, including a control group, a PD model group, a NEC-1 (6.5 mg/kg) treatment group, two TGY treatment groups at 5 and 2.

View Article and Find Full Text PDF

Background: Guidelines recommend leaving in situ rectosigmoid polyps diagnosed during colonoscopy that are 5 mm or smaller if the endoscopist optically predicts them to be non-neoplastic. However, no randomised controlled trial has been done to examine the efficacy and safety of this strategy.

Methods: This open-label, multicentre, non-inferiority, randomised controlled trial enrolled adults age 18 years or older undergoing colonoscopy for screening, surveillance, or clinical indications across four Italian centres.

View Article and Find Full Text PDF

Assessment of the role of probiotics in prevention of ventilator-associated pneumonia in neonates.

Eur J Pediatr

September 2025

Pediatrics Department, Faculty of Medicine, Gharbia Governorate, El Bahr St., Tanta Qism 2, Tanta, 31527, Egypt.

Purpose: Ventilator-associated pneumonia (VAP) is a severe complication in NICUs. It increases morbidity, mortality, and healthcare costs. The research purpose was to evaluate the preventive value of probiotics on the incidence of VAP among ventilated neonates.

View Article and Find Full Text PDF

The Consortium to Inform Molecular and Practical Approaches to Central Nervous System Tumor Taxonomy (cIMPACT-NOW) updates provide guidelines for the diagnosis of central nervous system (CNS) tumors and suggestions for future World Health Organization (WHO) classification. Following publication of the fifth edition WHO Classification of CNS Tumors (WHO CNS5) in 2021, the cIMPACT-NOW working group "Clarification" reviewed WHO CNS5 and prioritized two topics for further elucidation: (a) distinction of Glioblastoma, IDH-wildtype from Diffuse pediatric-type high-grade glioma, H3-wildtype, and IDH-wildtype and (b) clarification of subgroups of posterior fossa (PF) ependymal tumors. Recommendations regarding the IDH- and H3-wildtype diffuse high-grade gliomas include: (1) use caution assigning CNS WHO grade 4 (diagnosis of Glioblastoma, IDH-wildtype) to a "TERT promoter only", histologically low-grade, IDH-wildtype tumor; (2) EGFR gene amplification and +7/-10 chromosome copy number alterations should not be used as solitary defining features for diagnosing high-grade gliomas as Glioblastoma, IDH-wildtype in patients <40 years of age; (3) Diffuse pediatric-type high-grade glioma, H3-wildtype, and IDH-wildtype should be considered in the differential diagnosis in adults, especially those <40 years of age; (4) PDGFRA alteration, EGFR alteration, or MYCN amplification count as key molecular features of Diffuse pediatric-type high-grade glioma, H3-wildtype, and IDH-wildtype only in patients <25 years.

View Article and Find Full Text PDF